Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Myt Netherlands Parent B.V. ADR (NY: MYTE )

3.880 UNCHANGED
Streaming Delayed Price Updated: 7:00 PM EDT, Sep 9, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open 3.880
Bid (Size) 3.060 (1)
Ask (Size) 4.490 (1)
Prev. Close 3.880
Today's Range 3.880 - 3.880
52wk Range 2.050 - 6.270
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Mytheresa Announces Fourth Quarter and Full Fiscal Year 2024 Earnings Release and Conference Call
From MYT Netherlands Parent B.V.
Via Business Wire
Why Ovid Therapeutics Shares Are Trading Lower By 19%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Via Benzinga

Performance

YTD
+19.38%
+19.38%
1 Month
+4.86%
+4.86%
3 Month
-35.33%
-35.33%
6 Month
-0.51%
-0.51%
1 Year
+14.12%
+14.12%

More News

Read More
Mytheresa to Participate in Upcoming Investor Conferences
From MYT Netherlands Parent B.V.
Via Business Wire
Earnings Scheduled For February 15, 2024
Via Benzinga
Earnings Outlook For MYT Netherlands Parent
Via Benzinga
A Preview Of MYT Netherlands Parent's Earnings
Via Benzinga
Analyst Expectations for MYT Netherlands Parent's Future
Via Benzinga
MYTE Stock Earnings: MYT Netherlands Parent Beats EPS, Beats Revenue for Q3 2024
Via InvestorPlace
Q3 FY24 Results: Mytheresa Posts +18% Net Sales Growth and a Significantly Improved Adjusted EBITDA Margin Compared to the Previous Year Quarter
From MYT Netherlands Parent B.V.
Via Business Wire
Mytheresa Announces Preliminary Third Quarter Results – Double-Digit Topline Growth Significantly Improved Profitability
From MYT Netherlands Parent B.V.
Via Business Wire
Ermenegildo Zegna Reports FY23 Results, Joins Altice USA, Herbalife And Other Big Stocks Moving Lower On Friday
Via Benzinga
Topics Stocks
Exposures US Equities
Q2 FY24 Results: Mytheresa posts positive growth and strong financial results outperforming a consolidating market
From MYT Netherlands Parent B.V.
Via Business Wire
Mytheresa Announces Second Quarter of Fiscal Year 2024 Earnings Release and Conference Call; Participating in Upcoming Investor Conferences
From MYT Netherlands Parent B.V.
Via Business Wire
Q1 FY24 Results: Mytheresa Grows +7% in Net Sales in the First Quarter
From MYT Netherlands Parent B.V.
Via Business Wire
Earnings Scheduled For November 28, 2023
Via Benzinga
Why Shapeways Holdings Shares Are Trading Lower By Around 20%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Via Benzinga
12 Consumer Discretionary Stocks Moving In Wednesday's Intraday Session
Via Benzinga
Why CorMedix Shares Are Trading Higher By Over 19%; Here Are 20 Stocks Moving Premarket
Via Benzinga
12 Consumer Discretionary Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
Mytheresa Announces First Quarter of Fiscal Year 2024 Earnings Release and Conference Call
From MYT Netherlands Parent B.V.
Via Business Wire
12 Consumer Discretionary Stocks Moving In Wednesday's After-Market Session
Via Benzinga
Benzinga's 'Stock Whisper' Index: 5 Stocks Investors Are Secretly Monitoring But Not Talking About Yet
Via Benzinga
Why MYT Netherlands Parent Stock Is Soaring Today
Via The Motley Fool
Nasdaq Surges 100 Points; First Wave BioPharma Shares Spike Higher
Via Benzinga
Topics Stocks
Exposures US Equities
Why Clearmind Medicine Shares Are Trading Lower By 53%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.